Translational Medicine

An increasingly important biomedical speciality

Webinars, events, articles and multi-media lectures

Back

Kasra Shakeri-Nejad

Global Head Clinical Pharmacology, Translational Medicine

Novartis Institutes for Biomedical Research

Kasra Shakeri-Nejad received his MD from the Charité, Faculty of Medicine of the Humboldt University Berlin and completed his Doctoral Thesis at the Charité Berlin in the Department of Neurosurgery. He received his advanced medical training in Neurology and holds a board certification as Medical Expert in Clinical Pharmacology.

He has 23 years of experience in clinical drug development with primary focus on neuropsychiatric disorders in different roles in the biopharmaceutical industry and as a principal investigator in CROs.
Kasra joined Novartis as a TME in Neuroscience in 2011 and has led the development of many neuroscience drugs at Novartis. He was responsible for the Clinical Pharmacology components of the development and the successful NDA submission and market launch of Mayzent (siponimod) in MS.

Since February 2022 Kasra is leading Translational Medicine Clinical Pharmacology, a cross-functional team which is specialized in the design, clinical execution and reporting of First-in-Human (FiH) and Clinical Pharmacology studies across all TM therapeutic areas.

Webinars, events, articles and multi-media lectures

Sign up to hear from us:

CONTACT US
Ruskin House, 40-41 Museum Street, London WC1A 1LT, UK

Henry Stewart Conference Studies LLP is a limited liability partnership, registered in England, registration number OC334769 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events Ltd is a limited company, registered in England, registration number 06532399 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events, Inc. is a corporation incorporated in the State of Delaware, USA having a business office at PKF O’Connor Davies LLP, 665 Fifth Avenue, New York NY 10022.
© Henry Stewart Conference Studies LLP or its affiliates.